Gordon Dunn is Chief Financial Officer of Quoin Pharmaceuticals, Ltd.. Currently has a direct ownership of 28,856 shares of QNRX, which is worth approximately $15,293. The most recent transaction as insider was on Sep 10, 2024, when has been sold 20,000 shares (Ordinary Shares) at a price of $0.81 per share, resulting in proceeds of $16,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.9K
n/a 3M change
n/a 12M change
Total Value Held $15,293

Gordon Dunn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 10 2024
BUY
Open market or private purchase
$16,200 $0.81 p/Share
20,000 Added 40.94%
28,856 Ordinary Shares
Sep 09 2024
BUY
Open market or private purchase
$6,996 $0.79 p/Share
8,856 Added 50.0%
8,856 Ordinary Shares
GD

Gordon Dunn

Chief Financial Officer
Ashburn, VA

Track Institutional and Insider Activities on QNRX

Follow Quoin Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QNRX shares.

Notify only if

Insider Trading

Get notified when an Quoin Pharmaceuticals, Ltd. insider buys or sells QNRX shares.

Notify only if

News

Receive news related to Quoin Pharmaceuticals, Ltd.

Track Activities on QNRX